Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

✍ Scribed by Schwartzberg, Lee S.; Wang, Grace; Somer, Bradley G.; Blakely, L. Johnetta; Wheeler, Benton M.; Walker, Mark S.; Stepanski, Edward J.; Houts, Arthur C.

• Book ID: 123430274
• Publisher: CIG Media Group, LP.
• Year: 2014
• Tongue: English
• Weight: 276 KB
• Volume: 14
• Category: Article
• ISSN: 1526-8209
• DOI: 10.1016/j.clbc.2013.09.003